Glucose Management Technologies for the Critically Ill.

Link to article at PubMed

Glucose Management Technologies for the Critically Ill.

J Diabetes Sci Technol. 2019 Jan 13;:1932296818822838

Authors: Salinas PD, Mendez CE

Hyperglycemia is common in the intensive care unit (ICU) both in patients with and without a previous diagnosis of diabetes. The optimal glucose range in the ICU population is still a matter of debate. Given the risk of hypoglycemia associated with intensive insulin therapy, current recommendations include treating hyperglycemia after two consecutive glucose >180 mg/dL with target levels of 140-180 mg/dL for most patients. The optimal method of sampling glucose and delivery of insulin in critically ill patients remains elusive. While point of care glucose meters are not consistently accurate and have to be used with caution, continuous glucose monitoring (CGM) is not standard of care, nor is it generally recommended for inpatient use. Intravenous insulin therapy using paper or electronic protocols remains the preferred approach for critically ill patients. The advent of new technologies, such as electronic glucose management, CGM, and closed-loop systems, promises to improve inpatient glycemic control in the critically ill with lower rates of hypoglycemia.

PMID: 30638048 [PubMed - as supplied by publisher]

Leave a Reply

Your email address will not be published. Required fields are marked *